RheumaDATA - Rheumatology in Hamburg
Transcription
RheumaDATA - Rheumatology in Hamburg
Publikationen RheumaDATA: Versorgungsforschung für die Rheumatoide Arthritis Aries PM; Wassenberg S, Fliedner G, Amberger C, Vollberg C, Neuwirth J Braner A DGRh 2015 Verträglichkeit von Tocilizumab bei jungen Erwachsenen mit einer juvenilen idiopathischen Arthritis (JIA) Klotsche J Niewert M; Haas JP; Aries PM; Ochs W; Zink A; Horneff; Minden K DGRh 2015 Non-Response to Anti-Tnf Treatment in Psoriatic Arthritis Can be Predicted By an Objective Automated Measurement of Fluorescence-Signal Intensities in Fluorescence-Optical Imaging Technique – the First Interims Analysis of the Xpore-Study Michaela Koehm, Tanja Rossmanith, Ulf Henkemeier, Peer Aries, Rieke Alten, HansEckhard Lager, Harald Burkhardt, and Frank Behrens ACR/ARHP Annual Meeting 2015 Non-Interventional Clinical Study Investigating the Use of Goliumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in German – 3rd Interim Analysis Matthias H. Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Buehler, Jan BrandtJuergens, Verena Rickert and Siegfried Wassenberg ACR/ARHP Meeting 2015 Sozio- und gesundheitsökonomische Parameter bei Patienten mit RA, PsA und AS in einer nicht-interventionellen klinischen Erhebung unter Golimumab – GO-NICE 3. Interimsanalyse Matthias Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Bühler, Jan Brandt-Jürgens, Verena Rickert DGRh 2015 Messung des patientenrelevanten Nutzens bei rheumatoider Arthritis und multipler Sklerose Christine Blome, Helen Beckmann, Christoph Heesen, Peer M. Aries, Nicolaj Witt, Matthias Augustin DKVF 2015 Lebensqualität von Patienten mit RA, PsA und AS in einer nichtinterventionellen klinischen Erhebung unter Golimumab – GO-NICE 3. Interimsanalyse Matthias Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Bühler, Jan Brandt-Jürgens, Verena Rickert DGRh 2015 B-cell targeted therapy in patients with granulomatosis with polyangiitis and microscopic polyangiitis Moosig F, Aries PM, de Groot K, Hauitz M, Hellmich B, Iking-Konert C, Wagner AD, Zänker M Dtsch Med Wochenschr. 2014 Oct; 139/44):2248-53. Doi: 10.1055/s-0034-1387327. Epub 2014 Oct 21. Review. German. PubMed PMID: 25334077 Vasculitis: update 2014 Fleck M, Aries PM, Iking-Konert C. Dtsch Med Wochenschr. 2014 Jun; 139(23): 1234-6. Doi: 10.1055/s-0034-1370063. Epub 2014 May 27. Review. German. PubMed PMID: 24866957. Therapieentscheidungen bei RA-Patienten nach DMARD-Versagen – klinischer Alltag vs. Therapieempfehlungen PM. Aries, R. Dockhorn, A. Maltzahn, LG Meier, S. Petrat, U. Prothmann, C. Stille, H. Strothmeyer, MA Vollmer DGRh 2014 Rituximab in Rheumatoid Arthritis – 4 Years Interim Analysis oft he NonInterventional BRIDGING Study A. Krause, P. Aries, HM. Lorenz, U. Müller-Ladner, G. Neeck, H. Rusch, J. Wendler DGRh 2014 Nicht interventionelle Evaluierung: Klinisches Bild, Arbeitsfähigkeit und Lebensqualität unter Golimumab – 2. Interimsanalyse GO-NICE M. Thomas, K. Krüger, P. Aries, M. Bohl-Bühler, J. Brandt-Jürgens, V. Rickert DGRh 2014 DUO Registry Group. Functional impairment of systemic scleroderma patients with digital uclerations: results from the DUO Registry Guillevin L, Hunsch E, Denton CP, Krieg T, Schwierin B, Rosenberg D, MatucciCerinic M in Vertretung der DUO-Studiengruppe Clin Exp Rheumatol. 2013 Mar-Apr; 31 (2 Suppl 76): 71-80. Epub 2013 Jul 22. PubMed PMID: 23910613 Rituximab in Rheumatoid Arthritits – Interim Analysis of the non-interventional Bridging Study A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, G. Neeck, H. Rusch, J. Wendler Ann Rheum Dis 2013; 72 (Suppl3) : 445 DUO Registry investigators. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, Zultak M, Matucci-Cerinic M in Vertretung der DUO Studiengruppe Ann Rheum Dis. 2012 May; 71(5): 718-21. Rituximab in Rheumatoid Arthritis – Interim Analysis of the non-interventional Bridging Study A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, J. Kandenwein, J. Wendler Ann Rheuma Dis 2012; 71 (Suppl3) : 667 Tocilizumab in Rheumatoid Arthritis – One Year Interim Analysis oft he noninterventional ICHIBAN-Study C. Specker, J. Kaufmann, M.A. Vollmer, H. Kellner, M. Bohl-Bühler, M. Aringer, A. Alberding, H. Schwenke, C. Kühne, K. Lüthke, H. P. Tony, S. Zinke, A. Kapelle, T. Klopsch, P. M. Aries, S. Remstedt, A. Melzer, P. Hellmann, S. Türk, G. Fliedner Ann Rheum Dis 2012; 71 (Suppl3) : 667 GO-NICE: Interim-analysis of patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis treated with Golimumab in a real-life setting in Germany Dr. Kathrin Nickel, Dr. med. Peer Aries, Martin Bohl-Bühler, PD Dr. med. Jan BrandtJürgens, Dr. med. Ilka Schwarze, Dr. med. Silke Zinke, Dr. med. Markus Peceny DGRh 2012 Wirksamkeit und Sicherheit einer sequentiellen Therapie mit Tocilizumab (TCZ) und – bei zunächst inadäquater Response auf TCZ – gefolgt von Rituximab (RTX), in DMARD-IR Patienten mit RA (MIRAI-Studie) – 1. Interimsanalyse Prof. Dr. med. Thomas Dörner, Prof. Dr. med. Hans-Peter Tony, Prof. Dr. med. Hendrik Schulze-Koops, Dr. med. Peer Aries, Dr. med. Sylvia Berger, Dr. med. Werner A. Biewer, PD Dr. med. Jan Brandt-Jürgens, Prof. Dr. med. Jürgen Braun, Dr. med. Andreas Engel, Prof. Dr. med. Martin Fleck, Dr. med. Ino Kungdo, Dr. med. Irmgard Gürtler, Dr. Maria Höhle, Dr. med. Jörg Kaufmann, Prof. Dr. med. Herbert Kellner, Prof. Dr. med. Andreas Krause, Prof. Dr. med. Klaus Krüger, Dr. Reiner Kurthen, Dr. med. Thomas Neumann, Dr. med. Wolfgang Ochs, Prof. Dr. med. Andrea Rubbert-Roth, Dr. med. Holger Schwenke, Prof. Dr. med. Christof Specker, Dr. med. Herbert Voigt, Prof. Dr. med Peter Wagener, Dr. Sylke Wagner, Dr. Jochen Walter, Dr. med. Siegfried Wassenberg, Dr. med. Silke Zinke, Dr. Stefan Türk, PD Dr. med. Christof Iking-Konert DGRh 2012 GO-NICE: Interim-analysis of patients with Rheumatoid Arthritis treated with Golimumab in a real-life setting in Germany Nickel K, Aries PM, Bohl-Buehler M, Brandt-Juergens J, Braunewell V, Schwarze I, Zinke S, Peceny M ACR 2012 Rituximab in Rheumatoid Arthritis – Interim Analysis of the Non-Interventional Bridging Study A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, J. Kandenwein, J. Wendler, Ann Rheum Dis 2012; 71 (Suppl3):667 Frühdiagnose von Vaskulitiden B. Hellmich, P. Lamprecht, P. M. Aries, W. L. Gross Zeitschrift für Rheumatologie 04/2012, 0.46 Impact Factor PRESERVE-Studie Etanercept auch bei Patienten mit mittelschwerer RA wirksam P. M. Aries arthritis + rheuma 3/2012 Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma Karen Fröhlich, Julia U. Holle, Peer M. Aries, Wolfgang L. Gross, Frank Moosig Annals oft he rheumatic diseases 12/2010, 8.11 Impact Factor Ann Rheum Dis. 2011 Jul; 70(7): 1344-5. Rituximab bei rheumatoider Arthritis – Zwischenanalyse der nichtinterventionellen BRIDGING-Studie Prof. Dr. med. Andreas Krause, Dr. med. Peer Aries, Prof. Dr. Hannes-Martin Lorenz, Profl. Dr. med Ulf Ladner, Dr. Julia Kandenwein, Dr. med. Jörg Wendler DGRh 2009 Vasculitis. Treatment outcome parameters Aries PM, Gause A Z Rheumatol. 2009 Feb; 68(1):44-8. No seasonal variation in the onset of symptoms of 445 patients with Wegener’s granulomatosis Aries PM, Herlyn K, Reinhold-Keller E, Latza U Arthritis Rheum. 2008 Jun 15; 59(6):904. Clinical images: Saddlenose deformity caused by destructive granulomatous inflammation in Wegener’s granulomatosis Holl-Ulrich K, Both M, Gottschlich S, Gross WL, Aries PM, Lamprecht P Arthritis Rheum. 2008 Mar; 58(3): 834. The low-penetrance R92Q mutation oft he tumour necrosis factor superfamily 1A geneis neither a major risk factor for Wegener’s granulomatosis nor multiple sclerosis Jenne DE, Aries PM, Einwächter S, Akkad AD, Wieczorek S, Lamprecht P, Gross WL Ann Rheum Dis. 2007 Sep; 66(9):1266-7. Current state of biologicals in the management of systemic vasculitis Lamprecht P, Till A, Steinmann J, Aries PM, Gross WL Ann N Y Acad Sci. 2007 Sep; 1110:261-70. Review. PubMed PMID: 17911441 Biological therapies: New treatment options for ANCA-associated vasculitis? Aries PM, Lamprecht P, Gross WL Expert Opin Biol Ther. 2007 Apr; 7(4):521-33. Review. PubMed PMID: 17373903 Report on the 34th meeting of the German Clinical Immunology Workgroup, Frankfurt Aries PM, Witte T, Lamprecht P Z Rheumatol. 2007 Feb; 66(1):66(1):63-4. German. PubMed PMID:17160656 A case of destructive Wegener’s granulomatosis complicated by cytomegalovirus infection Aries PM, Ullrich S, Gross WL Nat Clin Pract Rheumatol. 2006 Sep; 2(9):511-5. PubMed PMID: 16951706 Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis Both M, Aries PM, Müller-Hülsbeck S, Jahnke T, Schäfer PJ, Gross WL, Heller M, Reuter M Ann Rheum Dis. 2006 Sep; 65(9):1124-30. Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations Aries PM, Hellmich B, Voswinkel J, Both M, Nölle B, Holl-Ulrich K, Lamprecht P, Gross WL Ann Rheum Dis. 2006 Jul; 65(7):853-8. Rituximab in refractory Wegener’s granulomatisis: Favorable or not? Aries PM, Lamprecht P, Gross WL Am J Respir Crit Care Med. 2006 Apr 1; 173(7):815-6; Nonsystemic vasculitic neuropathy: A clinicopathological study of 22 cases Aries PM, Gross WL J Rheumatol. 2006 Mar; 33(3):636; author reply 636-7. Diagnosis and therapy of ANCA-associated vasculitis Aries PM, Hellmich B, Gross WL Dtsch Med Wochenschr. 2006 Mar 3; 131(9):443-6. Intravenous immunoglobulin therapy in vasculitis: Speculation or evidence? Aries PM, Hellmich B, Gross WL Clin Rev Allergy Immunol. 2005 Dec; 29(3):237-45. Wegener’s granulomatosis: A view from the granulomatous side of the disease Aries PM, Lamprecht P, Gross WL Isr Med Assoc J. 2005 Dec; 7(12):768-73. Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group. Current status of outcome measures in vasculitis: Focus on Wegener’s granulomatosis and microscopic polyangiitis Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, Cuthbertson D, Felson DT, Hellmich B, Hoffmann GS, Jayne DR, Kallenberg CG, Krischer J, Mahr A, Matteson EL, Specks U, Luqmani R, Stone J Report from OMERACT 7. J Rheumatol. 2005 Dec; 32/12):2488-95. The PTPN22 620W allele is a risc factor for Wegener’s granulomatosis Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, Gross WL, Epplen JT Arthritis Rheum. 2005 Dec; 52(12):4039-43. Early diagnosis of vasculitides Hellmich B, Lamprecht P, Aries PM, Gross WL Z Rheumatol. 2005 Nov; 64(8):538-46. Review. Symmetric polyarthritis in a patient with Churg-Strauss Syndrome Aries PM, Reinhold-Keller E Dtsch Med Wochenschr. 2005 Aug 19; 130(33):1871-3. Glucocorticoids: importance in the treatment of vasculitis Aries PM; Hellmich B, Gross WL Z Rheumatol. 2005 Apr; 64(3): 155-61. Periostitis as the initial manifestation of systemic vasculitis Aries PM, Reuter M, Lamprecht P, Gross WL Ann Rheum Dis. 2005 Feb; 64(2):329-30. Images in clinical medicine. Destructive eye lesions in Wegener’s granulomatosis Aries PM, Both M N Engl J Med. 2005 Jan 27; 352(4):392. EURORITS: Rheumatology education in Europe under scrutiny. Preliminary results of a European survey Aries PM, Amital H, Lane SE Z Rheumatol. 2004 Oct; 63(5):428-9. High-dose intravenous azathioprine pulse treatment in refractory Wegener’s granulomatosis Aries PM, Hellmich B, Reinhold-Keller E, Gross WL Rheumatology (Oxford). 2004 Oct; 43(10):1307-8. Predicting mortality in systemic Wegener’s granulomatosis: Comment on the article by Bligny et al Reinhold-Keller E, Aries PM, Gross WL Arthritis Rheum. 2004 Oct 15; 51(5):868-9; Primary systemic vasculitides: Diagnostic pathways Hellmich B, Voswinkel J, Aries PM, Gross WL Dtsch Med Wochenschr. 2004 Jun 4; 129(23):1322-7. Review. Another look at Wegener’s granulomatosis-associated pachymeningitis Aries PM, Reinhold-Keller E, Gross WL J Rheumatol. 2004 Apr; 31(4):825; Author reply 825-6. Interdisciplinary rheumatology: State oft he Art in Vasculitis Summer Academy 04/05 July 2003, Bad Bramstedt Aries PM Z Rheumatol. 2003 Oct; 62(5):481-3. Subcutaneous magnesium pump in a patient with combined magnesium transport defect Aries PM, Schubert M, Müller-Wieland D, Krone W Dtsch Med. Wochenschr. 2000 Aug 18; 125(33):970-2.